These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 3938018)
21. [Features of bacteria elimination in patients with tuberculosis of the lungs]. Dzis' Ei; Kuz'minskaia AF; Samarskiĭ VA Vrach Delo; 1988 May; (5):68-9. PubMed ID: 3138823 [No Abstract] [Full Text] [Related]
22. [Role of bacteriological research in the the expertise of the work capacity of patients with respiratory organ tuberculosis]. Gavrilenko AF; Beliakova OI; Khoma OA Probl Tuberk; 1985; (8):12-5. PubMed ID: 3932997 [No Abstract] [Full Text] [Related]
23. [Clinical aspects of a single established isolation of mycobacteria]. Antipova SI; Bogomazova AV; Titova NF Probl Tuberk; 1986; (9):23-5. PubMed ID: 3097629 [No Abstract] [Full Text] [Related]
24. [Endogenous reactivation of tuberculosis as a result of reversion of persistent mycobacterial L-forms]. Dorozhkova IR; Zemskova ZS; Krudu VN; Kochetkova EIa Probl Tuberk; 1995; (3):43-6. PubMed ID: 7617636 [TBL] [Abstract][Full Text] [Related]
25. [Isolation of bacteria from pulmonary tuberculosis patients with no destructive lesions]. Pashkov IuN; Pospelov VV; Kulik EI Probl Tuberk; 1984 Nov; (11):56-8. PubMed ID: 6441163 [No Abstract] [Full Text] [Related]
26. [Prognostic value of isolation of L-forms of Mycobacterium tuberculosis]. Golanov VS; Bukharin OV; Usviatsov BIa; Seliukova SA Probl Tuberk; 2002; (11):44-6. PubMed ID: 12501800 [TBL] [Abstract][Full Text] [Related]
27. [Diagnostic significance of isolating Mycobacterium tuberculosis L forms in patients at the sanatorium stage of treatment]. Samillo GK Probl Tuberk; 1986; (9):28-30. PubMed ID: 3097631 [No Abstract] [Full Text] [Related]
28. The conversion of sputum in tuberculosis. Xalabarder E Scand J Respir Dis Suppl; 1978; 102():68-9. PubMed ID: 98840 [No Abstract] [Full Text] [Related]
29. [Characteristics of bacterial discharge in patients with different forms of pulmonary tuberculosis]. Golanov VS; Andreev LP; Bogdalova VE; Meshcheriakov VG; Ushakova AG; Bondin SV Probl Tuberk; 1994; (5):43-5. PubMed ID: 7870727 [TBL] [Abstract][Full Text] [Related]
30. [Isolation of mycobacteria L forms as a prognostic criterion of recurrence and aggravation of tuberculosis in patients with extended residual tuberculous lesions of the lungs]. Dorozhkova IR; Karachunskiĭ MA; Abdullaeva ET; Gamzaeva NF; Kochetkova EIa Probl Tuberk; 1989; (3):14-8. PubMed ID: 2498865 [TBL] [Abstract][Full Text] [Related]
31. [The composition and drug sensitivity of a mycobacterial population in patients with suspected tuberculosis]. Dorozhkova IR; Badleeva MV; Skotnikova OI; Nosova EIu; Kupavtseva EA; Borisov SE; Moroz AM Probl Tuberk Bolezn Legk; 2005; (8):36-8. PubMed ID: 16209018 [TBL] [Abstract][Full Text] [Related]
32. [Cases of detection of Mycobacterium tuberculosis in patients with nonspecific diseases of the lungs]. Rudoĭ NM; Rashitova FA Ter Arkh; 1975; 47(8):108-9. PubMed ID: 810906 [No Abstract] [Full Text] [Related]
33. [Quantitative and qualitative characteristics of bacterial excretion in socially maladapted patients with pulmonary tuberculosis and outcomes of the process]. Bondin SV Probl Tuberk; 1992; (3-4):51-3. PubMed ID: 1528836 [TBL] [Abstract][Full Text] [Related]
34. [Significance of mycobacterial L forms in the development of pulmonary tuberculosis relapses]. Salobaĭ RIu; Berezovskiĭ BA; Golanov VS Vrach Delo; 1981 Dec; (12):77-80. PubMed ID: 6800136 [No Abstract] [Full Text] [Related]
35. [Persistance of the agent of tuberculosis in the body as an L-form and its damging effect]. Shmelev NA; Dorozhkova IR; Zemskova ZS Vestn Akad Med Nauk SSSR; 1976; (5):29-37. PubMed ID: 823731 [No Abstract] [Full Text] [Related]
36. [Use of bacteriological method for the diagnosis of tuberculosis in non-transportable patients with chronic generalized diseases]. Dukarskiĭ BG; Edel'shteĭn LL; Andreeva TT; Batutin VI; Bystrova ZN Probl Tuberk; 1981 Mar; (3):12-4. PubMed ID: 6453338 [No Abstract] [Full Text] [Related]
37. [Clinical value of determining Mycobacterium tuberculosis in sputum and bronchial washings]. Rudoĭ NM; Eliseev VV; Asambaev AA; Temirgalieva RU Lab Delo; 1970; 10():614-8. PubMed ID: 4099567 [No Abstract] [Full Text] [Related]
38. [Estimation of the degree of risk of reactivation of residual tuberculous changes based on the status of mycobacterial population]. Krudu VN; Dorozhkova IR Probl Tuberk; 1992; (5-6):45-7. PubMed ID: 1409517 [TBL] [Abstract][Full Text] [Related]
39. [Evaluation of culturing for mycobacterium tuberculosis bacterioscopically-negative sputum and bronchial washings]. Mogilevtsev PT; Lisitsyna NM; Pershina AD Vrach Delo; 1971 Oct; 10():85-6. PubMed ID: 5003979 [No Abstract] [Full Text] [Related]
40. Chemotherapy of chronic destructive tuberculosis of the lungs and some disputable drugs. Schmelev NA Scand J Respir Dis Suppl; 1968; 65():147-50. PubMed ID: 4978458 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]